Basecamp Research builds and trains EDEN, a family of evolutionary AI models powered by BaseData™, the world’s largest privately collected genomics dataset spanning over 10 trillion DNA tokens from more than one million newly discovered species. Working with NVIDIA, the company has created the first AI models shown to design enzymes capable of large, precise gene insertions in the human genome, overcoming key limitations of CRISPR-based editing. In laboratory studies, these models generated active insertion proteins for 100% of tested disease-relevant sites and produced CAR-T cells that achieved more than 90% tumour-cell clearance. The same platform also designed antimicrobial peptides with a 97% success rate against multidrug-resistant pathogens. Computation for the largest model consumed 1.95 × 10²⁴ FLOPS on 1,008 NVIDIA Hopper GPUs, placing it among the most compute-intensive biological models reported. Leveraging these capabilities, Basecamp is advancing an internal pipeline of cell and gene therapies targeting cancer and inherited diseases while collaborating with biopharma and academic partners worldwide. The company’s recent financing activity indicates continued investment in scaling R&D and preparing for a forthcoming Series C round.

Total raised

$80M

Funding rounds

3

Latest round

Series A

Latest activity

Dec 2022